Loading...

Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 111.08 USD -0.64% Market Closed
Updated: Feb 6, 2023

Intrinsic Value

The intrinsic value of one ABT stock under the Base Case scenario is 94.26 USD. Compared to the current market price of 111.08 USD, Abbott Laboratories is Overvalued by 15%.

The Intrinsic Value is calculated as the average of the two valuation methods:

ABT Intrinsic Value
Base Case
94.26 USD
Overvaluation 15%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

ABT Profitability Score
Profitability Due Diligence

Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROIC
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
Positive ROIC
62/100
Profitability
Score

Abbott Laboratories's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

ABT Solvency Score
Solvency Due Diligence

Abbott Laboratories's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Short-Term Liabilities
Long-Term Liabilities
Low D/E
74/100
Solvency
Score

Abbott Laboratories's solvency score is 74/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
56%
Gross Margin
20%
Operating Margin
16%
Net Margin
20%
FCF Margin
19%
ROE
12%
ROIC
Other

ABT Capital Structure
Abbott Laboratories

Market Capitalization 194B USD
Total Debt 15.3B USD
Minority Interest 209M USD
Preferred Equity 0 USD
Cash and Equivalents 9.6B USD
Short-Term Investments 313M USD
Enterprise Value 199B USD

Wall St
Price Targets

ABT Price Targets Summary
Abbott Laboratories

Wall Street analysts forecast ABT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ABT is 122.18 USD with a low forecast of 92.92 USD and a high forecast of 151.2 USD.

Lowest
Price Target
92.92 USD
16% Downside
Average
Price Target
122.18 USD
10% Upside
Highest
Price Target
151.2 USD
36% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

ABT Competitors
Abbott Laboratories

ABT Suppliers & Customers
Abbott Laboratories

Abbott Laboratories has 65 key suppliers from 16 countries and 19 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Technology industry.

Suppliers Map

Abbott Laboratories has 17 key customers from 6 countries and 6 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

ABT Insider Trading
Buy and sell transactions by insiders

Abbott Laboratories insiders have only sold shares in the past 12 months.

During the last 12 months Abbott Laboratories insiders have not bought any shares, and sold 38.7M USD worth of shares. The last transaction was made on Feb 6, 2023 by Karam Sammy (SENIOR VICE PRESIDENT), who sold 457k USD worth of ABT shares.

Sold
0-3
months
1.7M USD
2
3-6
months
20.9M USD
3
6-9
months
5.8M USD
3
9-12
months
10.3M USD
14
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
1.7M USD
N/A
-1.7M
6 Months
22.6M USD
N/A
-22.6M
9 Months
28.4M USD
N/A
-28.4M
12 Months
38.7M USD
N/A
-38.7M
Purchases
17
Sales
416
No transactions found
Why is insider trading important?

Shareholder Return

ABT Price
Abbott Laboratories

1M 1M
-1%
6M 6M
+2%
1Y 1Y
-13%
3Y 3Y
+29%
5Y 5Y
+103%
Annual Price Range
111.08
52w Low
95.06
52w High
129.4
Price Metrics
Average Annual Return 25.93%
Standard Deviation of Annual Returns 4.29%
Max Drawdown -32%
Shares Statistics
Market Capitalization 194B USD
Shares Outstanding 1 743 570 048
Percentage of Shares Shorted 0.92%

Company Profile

Abbott Laboratories

Country

United States of America

Industry

Health Care

Market Cap

194B USD

Dividend Yield

1.83%

Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois and currently employs 113,000 full-time employees. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Contact

ILLINOIS
ABBOTT PARK
100 Abbott Park Rd
+12246676100.0
https://www.abbott.com/

IPO

1937-03-01

Employees

113 000

Officers

Chairman, Pres & CEO
Mr. Robert B. Ford
Exec. VP of Fin. & CFO
Mr. Robert E. Funck Jr.
Exec. VP, Gen. Counsel & Sec.
Mr. Hubert L. Allen
Exec. VP and Group Pres of Established Pharmaceuticals & Nutritional Products
Mr. Daniel Gesua Sive Salvadori
Exec. VP of Rapid & Molecular Diagnostics
Ms. Andrea F. Wainer
VP of Investor Relations, Licensing & Acquisitions
Mr. Scott Michael Leinenweber
Show More
VP and Chief Ethics & Compliance Officer
James E. Young
VP of Public Affairs & Corp. Marketing
Ms. Melissa Brotz
Sr. VP and Chief Marketing & External Affairs Officer
Ms. Elaine R. Leavenworth
Exec. VP of HR
Ms. Mary K. Moreland
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one ABT stock?

The intrinsic value of one ABT stock under the Base Case scenario is 94.26 USD.

Is ABT stock undervalued or overvalued?

Compared to the current market price of 111.08 USD, Abbott Laboratories is Overvalued by 15%.